DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF) is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.
DIAGNOS Inc.
Disclaimer: All stock information on InvestorNews.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.
InvestorNews Features on DIAGNOS Inc.
-
André Larente on DIAGNOS’ Partnership with EssilorLuxottica to Expand AI Retinal Analysis and Offers Updates on Regulatory Approvals
September 09, 2024 — In a recent interview with InvestorNews host Pat Bolland, André Larente, President, CEO, and Director…
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Thursday, September 5, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 5th, at 9 AM EST,…
-
André Larente from DIAGNOS on Transforming Optometry and Expanding AI Capabilities
April 29, 2024 — In a recent interview with InvestorNews host Tracy Weslosky, André Larente, President, CEO, and…
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
Andre Larente from DIAGNOS on Deal with World’s Largest Eyecare Retailer EssilorLuxottica
InvestorNews host Tracy Weslosky recently conducted an insightful interview with André Larente, President and Director of DIAGNOS Inc.…
-
Investor.Coffee (12.11.2023): CDN Healthcare Deal, U.S. Dollar Gains Strength on Japan’s Nikkei Rebound
DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF), a company we have followed for several years out of Montreal, announced…
-
Applying AI for the good of humanity, a tool for early detection of preventable blindness in diabetes patients is here
Is Artificial Intelligence (AI) going to save the world? Likely not if you are a fan of the…